Related Experiment Videos
Review of toxicity and long-term sequelae in lung cancer
1Institut Gustave-Roussy, Villejuif, France.
Antibiotics and Chemotherapy
|January 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Developments in the treatment of early NSCLC: when to use chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Adjuvant chemotherapy for resectable non-small-cell lung cancer: where is it going?
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?
Annals of oncology : official journal of the European Society for Medical Oncology·2010
Anticoagulant prophylaxis and therapy in patients with cancer.
Antibiotics and chemotherapy·2000
Serum and plasma parameters in clinical evaluation of neutropenic fever.
Antibiotics and chemotherapy·2000